Position
Chief Medical Officer
Company
Tavo Biotherapeutics
MemphisBiotechnologyHealth CareTherapeuticsDescription
Tavo Biotherapeutics has appointed Federico Grossi, M.D., Ph.D., as Chief Medical Officer to lead the company's clinical development strategy and execution. This appointment comes alongside a successful $17 million Series A financing.
Quick answer
Tavo Biotherapeutics Appoints Federico Grossi as Chief Medical Officer (June 2, 2026). Tavo Biotherapeutics is based in Memphis, Tennessee, United States.
- Who is the new Chief Medical Officer at Tavo Biotherapeutics?
- Tavo Biotherapeutics named Federico Grossi Chief Medical Officer, announced June 2, 2026.
- What did Tavo Biotherapeutics announce on June 2, 2026?
- Tavo Biotherapeutics has appointed Federico Grossi, M.D., Ph.D., as Chief Medical Officer to lead the company's clinical development strategy and execution. This appointment comes alongside a successful $17 million Series A financing.
- What does Tavo Biotherapeutics do?
- Tavo Biotherapeutics is developing innovative treatments to address critical unmet needs in ophthalmology.
- Where is Tavo Biotherapeutics based?
- Tavo Biotherapeutics is based in Memphis, Tennessee, United States.
- Which similar companies made leadership changes around the same time?
- Pictor (June 2, 2026), Cue Biopharma (June 2, 2026), Waypoint Bio (June 1, 2026) and Revium Rx (June 1, 2026) also announced leadership changes within 45 days of Tavo Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pictor Holdings Inc. Appoints Terry Kelly as Chief Operating Officer and Tim Shannon as Chief Financial Officer (June 2, 2026)
- Cue Biopharma Appoints Sumita Ray as Chief Legal & Compliance Officer (June 2, 2026)
- Waypoint Bio Appoints Dr. Patrick Kaifosh as Chief Technology Officer (June 1, 2026)
- Igor Bluvstein Appointed Chief Financial Officer at REVIUM Rx (June 1, 2026)
- Actinium Pharmaceuticals Appoints Steffen Heeger as Chief Medical Officer (June 1, 2026)
- Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer (June 3, 2026)
Who to call at Tavo Biotherapeutics, and when
A new leader at Tavo Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Tavo Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tavo Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tavo Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tavo Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tavo Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.